Approval the technolas 217a excimer laser system.  This device is indicated for laser in-situ keratomileusis (lasik) treatments:  1) for the reduction or elimination of myopic astigmatism up to -12.00 d mrse, with sphere between >-7.00 d to -10.99 d and cylinder between 0.00 and <-3.00 d;  2)  in patients with documented evidence of a change in manifest refraction of less than or equal to 0.50 diopters (in both cylinder and sphere components) for at least one year prior to the date of the pre-operative examination; and,  3) in patients who are 21 years of age or older.